According to current international practice guidelines, the disease phase of chronic hepatitis B (CHB) can be defined by three clinical laboratory parameters that determine the indication for antiviral treatment: alanine aminotransferase (ALT), HBV e antigen (HBeAg), and HBV DNA levels [2]. Here, GPT is linked to chronic hepatitis B virus infection.